Indication and contra-indications for cardiac catheterization

Slides:



Advertisements
Similar presentations
INTERVENTIONAL CARDIOLOGY AN OVERVIEW
Advertisements

Review.
Assisted Circulation MEDICAL MEDICAL  Drugs  EECP MECHANICAL  IABP ( Introaortic balloon pump)  VAD (Ventricular assist device)
Mohammed Almansori MBBS, FRCPC Assistant Professor of Medicine & Interventional Cardiologist University of Dammam ECHO CLUB INVASIVE HEMODYNAMIC EVALUATION.
Cardiac Stress Testing. What is a stress test? A progressive graded test that reproduces diagnostic, prognostic, and functional abnormalities in clients.
Introduction Recent guidelines considered PCI to be a potential alternative to CABG for ULMCA stenosis, based on several large registries and randomized.
Trileaflet Aortic Valve. Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Ischemic Heart Disease Group of diseases Most common cause of death in developed countries Terminology: 1.Angina pectoris 2.Myocardial infarction 3.Sudden.
Cardiac Arrhythmia. Cardiac Arrhythmia Definition: The pumping action of the heart is coordinated by an electrical system within the heart tissue.
CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O..
Modalities of Cardiac Stress Test
Ischemic Heart Diseases IHD
Archer USMLE Online Reviews USMLEGalaxy, LLC All Rights Reserved Sample Slides for Archer Rapid Review June 12 th to 14 th, 2009.
Diagnostic Stress Testing
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Angiography Excessive Commercialisation Complications of Angiography 1.Death 2.Myocardial Infarction Factors predisposing Unstable angina Angina at rest.
Arthur Stillman, M.D., Ph.D., PI Pamela Woodard, M.D., Study Co-chair Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic.
Primary Aim To compare outcomes of participants with symptoms of stable angina or angina equivalent evaluated with an anatomic imaging strategy using CCTA.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
C.H.T Dr.Salarifar 1 Tehran Heart Center Tehran University of Medical Sciences PCI VS CABG M. SALARIFAR, MD.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
1 Cardiovascular Testing J.B. Handler, M.D. Physician Assistant Program University of New England.
Dr. Adel El Banna M.D Consultant of Cardiac Surgery Head of Cardiac Surgery Department National Heart Institute.
Cardiogenic Shock Diagnosis, Treatment and Guidelines Mladen I. Vidovich, MD April 5, 2007.
Risk stratification and secondary prevention following acute myocardial infarction In-Ho Chae Department of Internal Medicine Seoul National University.
Majelle L. Gagtan. Definition Indications/Contraindications Running the Exercise Test Protocols.
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
Chapter 6 Diseases of the Cardiovascular System. Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. 1 Structures of the.
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Chapter 16 Assessment of Hemodynamic Pressures
Department of CTVS.  56 years old male from Cuttack  Date of admission  Date of surgery  Date of death  Diagnosis:
Cardiovascular disease in pregnancy Cardiovascular disease in pregnancy Dr.Z Allameh MD.
Risk Stratification In Patients With Chronic Myocardial Ischemia.
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
Sensitivity is True positives 60 Total CAD 100 Sensitivity and Specificity CAD by CAG No CAD by CAG TMT + VE True Positives 60 False Positives 60 TMT –
Pt’s treated with B-blockers post infarction are seen to have a significant reduction in re-infraction.
Update of 2013 ACCF/AHA Guidelines for STEMI Junbo Ge MD,FACC,FESC,FSCAI Zhongshan Hospital, Fudan University.
Adult Cardiac Valve Disease Marvin D. Peyton, M.D. Thoracic and Cardiovascular Surgery University of Oklahoma Health Sciences Center.
Cardiac Cath and Angiocardiography Adult II FINAL 2/2015.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.
Adult Echocardiography Lecture 10 Coronary Anatomy
Cardiovascular Pathology
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.
Patient Selection & Risk Stratification Soltani GH, MD.
Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
© free-ppt-templates.com 2017 AHA/ACC Focused Update of Valvular Heart Disease Guideline of 2014 DR. OMAR SHAHID TR CARDIOLOGY SZH.
Lesson 11.2 congenital heart disease (CHF) Atherosclerosis
Total Occlusion Study of Canada (TOSCA-2) Trial
ISCHEMIC HEART DISEASE
Case No #1 Viability assessment
Cardiothoracic Surgery
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Investigations of the Cardiovascular system
Percutaneous Coronary Interventions for Patients with Relative Contra-indications: Severely Depressed Left Ventricular Function Great Wall International.
CORONARY ARTERY DISEASE
Cardiac Cath NUR 422.
Section V: Erectile dysfunction: The patients you see
Cardiovascular System Notes
Acute Coronary Syndrome (1)
Presentation transcript:

Indication and contra-indications for cardiac catheterization PUMCH Shen zhujun

Cardiac catheterization For diagnosis Left heart cath.(inclu. CAG) : from artery, use a catheter to measure left cardiac chamber and large vessel pressure or CAG or blood gas measurement. Right heart cath. : from vein, use a catheter to measure the pressure, angiogram or blood gas sample, EP test or cardiac biopsy.

Coronary angiogram

For stable angina or ischemia without symptom AP CCS III or IV on medication (B) No matter the degree of AP, non-invasive test show high risk* (A) Aborted cardiac death, sustained VT (≥30sec) or non-sustained (<30sec) polymorphic VT (B)

High-risk CAD (annual death >3%) on non-invasive test Severe LV dysfunction rest (LVEF< 35%) High-risk on treadmill test (≤-11) Severe LV dysfunction on exertion (LVEF< 35%) Large area ischemic defect on stress test (esp. anterior wall, Dobutamine or the others) Multiple ischemic segment on sress test

For non-cardiac surgery assess the risk with know or suspect CAD High risk with non-invasive test (C) Angina refractory to medication (C) Unstable angina, esp. moderate or high risk surgery (C) Undetermined with non-invasive test with high risk clinical risk factors before high risk surgery (C)

For valve patient Adult valve patient with symptom need surgery or balloon therapy, non-invasive test suggest ischemia (B) After middle age (male 45, female 50) with some risk factors without symptom before surgery (C) Infective endocarditis with evidence of coronary embolism (C)

For heart failure patient CHF with systolic dysfunction with angina or segmental wall motion abnomality or any evidence of reversible ischemia (B) Before heart transplantation (C) CHF duo to MI with ventricular aneurysm or any mechanical complication (C)

For STEMI --- indication Suitable for primary or rescue PCI– within 12 hrs or over 12 hrs with persistent ischemia, cathlab facility needed (A) Cardiogenic shock need revascularization– 36 hrs from onset or 18 hrs after shock (A) Complicated with VSD or severe MR need repair (B) Complicated with persistent hemodynamic unstable or electrical unstable condition (C)

For STEMI --- contra-indication III Multiple co-morbidities, revascularization may not help the patient (C)

For UA/STEMI --- indication Recurrent ischemia after medication (B) Moderate or High risk:TIMI score≥3. Age≥65yrs; ≥3 CAD risk factors; Known CAD; Aspirin in past 7 days; Recent (within 24hrs) severe angina; ST deviation≥0.5mm; cardiac markers elevation (A). Low risk but non-invasive test show high risk:EF<0.35、large area ischemia (esp. anterior wall) or multiple segment ischemia (B) UA post-PCI or CABG (C) Prinzmetal angina (C)

For UA/STEMI --- contra-indication III Multiple co-morbiditis, cannot benefit from revascularization (C) Chest pain with low risk UA (C) Not a candidate for revascularization (C)

For recent MI --- indication Any ischemic evidence on low level stress test (B)

Relative contra-indication Unknow fever or fever not controlled Severe or acute liver or renal dysfunction or failure Severe anemia Severe electrolyte disturbance End stage carcinoma Aortic valve IE Severe bleeding disease or active bleeding

Relative contra-indication (Cont’) stroke (acute phase) Digoxin intoxication CHF not controlled Severe coagulation disease Patient can’t co-operate Any disease or condition make the patient can’t benefit from revascularization therapy

Factors increase the risk of CAG age> 70 yr Complicated congenital heart disease Severe obesity Cachexia Uncontrolled hyperglycemia Hypoxia Severe COPD CRF Hyperthyroidism

Factors increase the risk of CAG (cont’) Triple vessel disease Left main disease Heart failure, grade IV Severe mitral valve 、aortic valve disease or after mechanical valve replacement LVEF< 35 % High risk on treadmill test (with hypotension or severe ischemia) Pulmonary hypertension PCWP> 25 mm Hg

Factors increase the risk of CAG (cont’) Coagulation or bleeding disturbance Uncontrolled hypertension Severe peripheral artery disease Recent stroke Severe aortic insufficency

LV-gram indication Routine LV-gram should be done before or after CAG to evaluate the left ventricular function, mitral valve and aortic valve function LV was not done regularly in daily practice because the advantage of Echocardiography

LV-gram Contra-indication LV thrombus Severe LV dysfunction, LVEDP≥20mmHg

R-cath. Indication Complicated congenital heart disease need anatomical and physiological assessment. Congenital heart disease complicated with pulmonary hypertension EP test Cardiac biopsy

R-cath. Contra-indication Simple cases can be accurately diagnosed by echocardiography or other non-invasive procedures